NCT07766980 Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients Status RECRUITING Phase NA
NCT07608432 Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) Status RECRUITING Phase PHASE3
NCT07587242 A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping Status RECRUITING Phase PHASE3
NCT07287189 Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients Status RECRUITING Phase PHASE2
NCT07058662 A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. Status RECRUITING Phase PHASE1/PHASE2
NCT06581887 Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies Status RECRUITING Phase N/A
NCT06244082 Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05996003 NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) Status RECRUITING Phase PHASE2
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT04337112 The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation Status APPROVED_FOR_MARKETING Phase N/A
NCT03649919 Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children Status WITHDRAWN Phase N/A